Boston Scientific launches gel to prevent stone migration in
2 April 2012
Boston Scientific Corporation (NYSE: BSX) has launched
BackStop Gel, a new technology designed to prevent stone migration
during procedures used to break up and retrieve urinary stones. The
company is now marketing the product in the US and select international
BackStop Gel is a water-soluble polymer that urologists inject
into the ureter to form a plug behind the stone, preventing
migration of stone fragments of all sizes.
Stone migration is a common clinical challenge during stone
extraction and can result in increased procedure time, lower
stone-free rates and increased need for secondary procedures.
The BackStop Gel is placed with a catheter, which is then removed
to free up space in the operative field. Unlike prior generations of
antiretropulsion devices, BackStop Gel is designed without
mechanical components susceptible to damage from devices used to
fragment the stone. Upon completion of the procedure, the BackStop
Gel is designed to dissolve with conventional irrigation.
"I have found that using BackStop Gel in the ureter helps prevent
the migration of stones and increases the success rate of stone
removal," said Dianne Sacco, M.D., Director of Kidney Stone Program,
Massachusetts General Hospital in Boston. "This product provides a
non-traumatic plug, which enhances the use of lithotripsy devices to
successfully fragment and retrieve stones."
"We are focused on offering minimally invasive and cost-effective
medical devices that improve patient outcomes," said Michael Phalen,
Executive Vice President and President of the Boston Scientific
MedSurg Division. "The BackStop Gel demonstrates this focus by
providing a clinically effective method for urologists to manage the
common problem of stone migration during treatment procedures."